| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30005670 | HIV | ENSG00000213341.11 | protein_coding | CHUK | No | No | 1147 | O15111 |
| TVIS30000523 | HIV | ENSG00000213341.11 | protein_coding | CHUK | No | No | 1147 | O15111 |
| TVIS30000145 | HIV | ENSG00000213341.11 | protein_coding | CHUK | No | No | 1147 | O15111 |
| TVIS30085770 | HIV | ENSG00000213341.11 | protein_coding | CHUK | No | No | 1147 | O15111 |
| TVIS30075852 | HIV | ENSG00000213341.11 | protein_coding | CHUK | No | No | 1147 | O15111 |
| TVIS30085771 | HIV | ENSG00000213341.11 | protein_coding | CHUK | No | No | 1147 | O15111 |
| TVIS30028372 | HIV | ENSG00000213341.11 | protein_coding | CHUK | No | No | 1147 | O15111 |
| TVIS30028373 | HIV | ENSG00000213341.11 | protein_coding | CHUK | No | No | 1147 | O15111 |
| TVIS30028374 | HIV | ENSG00000213341.11 | protein_coding | CHUK | No | No | 1147 | O15111 |
| TVIS30028375 | HIV | ENSG00000213341.11 | protein_coding | CHUK | No | No | 1147 | O15111 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CHUK |
|---|---|
| DrugBank ID | DB00795 |
| Drug Name | Sulfasalazine |
| Target ID | BE0004655 |
| UniProt ID | O15111 |
| Regulation Type | |
| PubMed IDs | 9486988; 11054378; 11151876; 12950415 |
| Citations | Wahl C, Liptay S, Adler G, Schmid RM: Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998 Mar 1;101(5):1163-74. doi: 10.1172/JCI992.@@Weber CK, Liptay S, Wirth T, Adler G, Schmid RM: Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000 Nov;119(5):1209-18.@@Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K: Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol. 2000 Dec;95(12):3452-7.@@Allgayer H: Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment Pharmacol Ther. 2003 Sep;18 Suppl 2:10-4. |
| Groups | Approved |
| Direct Classification | Azobenzenes |
| SMILES | OC(=O)C1=CC(=CC=C1O)N=NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1 |
| Pathways | |
| PharmGKB | PA451547 |
| ChEMBL | CHEMBL421 |
